Chinese General Practice ›› 2020, Vol. 23 ›› Issue (30): 3884-3887.DOI: 10.12114/j.issn.1007-9572.2020.00.061
• Monographic Research • Previous Articles Next Articles
Published:
2020-10-20
Online:
2020-10-20
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2020.00.061
[1]GOWER-ROUSSEAU C,SARTER H,SAVOYE G,et al.Validation of the Inflammatory Bowel Disease Disability Index in a population-based cohort[J].Gut,2017,66(4):588-596.DOI:10.1136/gutjnl-2015-310151. [2]COLOMBEL J F,NARULA N,PEYRIN-BIROULET L.Management strategies to improve outcomes of patients with inflammatory bowel diseases[J].Gastroenterology,2017,152(2):351-361.e5.DOI:10.1053/j.gastro.2016.09.046. [3]DANESE S,FIORINO G,PEYRIN-BIROULET L.Early intervention in Crohn's disease:towards disease modification trials[J].Gut,2017,66(12):2179-2187.DOI:10.1136/gutjnl-2017-314519. [4]SIEGEL C A,WHITMAN C B,SPIEGEL B M R,et al.Development of an index to define overall disease severity in IBD[J].Gut,2018,67(2):244-254.DOI:10.1136/gutjnl-2016-312648. [5]中华医学会消化病学分会炎症性肠病学组.炎症性肠病诊断与治疗的共识意见(2012年?广州)[J].中华内科杂志,2012,51(10):818-831.DOI:10.3760/cma.j.issn.0578-1426.2012.10.024. [6]张明,王新颖.组织愈合在炎症性肠病诊治中的应用[J].中华消化杂志,2017,37(1):68-70.DOI:10.3760/cma.j.issn.0254-1432.2017.01.021. [7]PEYRIN-BIROULET L,SANDBORN W,SANDS B E,et al.Selecting therapeutic targets in inflammatory bowel disease (STRIDE):determining therapeutic goals for treat-to-target[J].Am J Gastroenterol,2015,110(9):1324-1338.DOI:10.1038/ajg.2015.233. [8]ZORZI F,STASI E,BEVIVINO G,et al.A sonographic lesion index for Crohn's disease helps monitor changes in transmural bowel damage during therapy[J].Clin Gastroenterol Hepatol,2014,12(12):2071-2077.DOI:10.1016/j.cgh.2014.04.036. [9]CIVITELLI F,NUTI F,OLIVA S,et al.Looking beyond mucosal healing:effect of biologic therapy on transmural healing in pediatric Crohn's disease[J].Inflamm Bowel Dis,2016,22(10):2418-2424.DOI:10.1097/MIB.0000000000000897. [10]FERNANDES S R,RODRIGUES R V,BERNARDO S,et al.Transmural healing is associated with improved long-term outcomes of patients with Crohn's disease[J].Inflamm Bowel Dis,2017,23(8):1403-1409.DOI:10.1097/MIB.0000000000001143. [11]DEEPAK P,FLETCHER J G,FIDLER J L,et al.Radiological response is associated with better long-term outcomes and is a potential treatment target in patients with small bowel Crohn's disease[J].Am J Gastroenterol,2016,111(7):997-1006.DOI:10.1038/ajg.2016.177. [12]LATERZA L,PISCAGLIA A C,MINORDI L M,et al.Multiparametric evaluation predicts different mid-term outcomes in Crohn's disease[J].Dig Dis,2018,36(3):184-193.DOI:10.1159/000487589. [13]PANéS J,RIMOLA J.Is the objective of treatment for Crohn's disease mucosal or transmural healing?[J].Clin Gastroenterol Hepatol,2018,16(7):1037-1039.DOI:10.1016/j.cgh.2018.03.034. [14]BRUINING D H,ZIMMERMANN E M,LOFTUS E V Jr,et al.Consensus recommendations for evaluation,interpretation,and utilization of computed tomography and magnetic resonance enterography in patients with small bowel Crohn's disease[J].Gastroenterology,2018,154(4):1172-1194.DOI:10.1053/j.gastro.2017.11.274. [15]MACONI G,NYLUND K,RIPOLLES T,et al.EFSUMB recommendations and clinical guidelines for intestinal ultrasound (GIUS) in inflammatory bowel diseases[J].Ultraschall Med,2018,39(3):304-317.DOI:10.1055/s-0043-125329. [16]SHAH S C,COLOMBEL J F,SANDS B E,et al.Systematic review with meta-analysis:mucosal healing is associated with improved long-term outcomes in Crohn's disease[J].Aliment Pharmacol Ther,2016,43(3):317-333.DOI:10.1111/apt.13475. [17]MACONI G,ARMUZZI A.Beyond remission and mucosal healing in Crohn's disease.Exploring the deep with cross sectional imaging[J].Dig Liver Dis,2017,49(5):457-458.DOI:10.1016/j.dld.2017.04.009. [18]DAPERNO M,CASTIGLIONE F,DE RIDDER L,et al.Results of the 2nd part Scientific Workshop of the ECCO.Ⅱ:Measures and markers of prediction to achieve,detect,and monitor intestinal healing in inflammatory bowel disease[J].J Crohns Colitis,2011,5(5):484-498.DOI:10.1016/j.crohns.2011.07.003. [19]CASTIGLIONE F,TESTA A,REA M,et al.Transmural healing evaluated by bowel sonography in patients with Crohn's disease on maintenance treatment with biologics[J].Inflamm Bowel Dis,2013,19(9):1928-1934.DOI:10.1097/MIB.0b013e31829053ce. [20]EDER P,KATULSKA K,KRELA-KAZMIERCZAK I,et al.The influence of anti-TNF therapy on the magnetic resonance enterographic parameters of Crohn's disease activity[J].Abdom Imaging,2015,40(7):2210-2218.DOI:10.1007/s00261-015-0466-0. [21]PREZZI D,BHATNAGAR G,VEGA R,et al.Monitoring Crohn's disease during anti-TNF-α therapy:validation of the magnetic resonance enterography global score (MEGS) against a combined clinical reference standard[J].Eur Radiol,2016,26(7):2107-2117.DOI:10.1007/s00330-015-4036-1. [22]STOPPINO L P,DELLA VALLE N,RIZZI S,et al.Magnetic resonance enterography changes after antibody to tumor necrosis factor (anti-TNF) alpha therapy in Crohn's disease:correlation with SES-CD and clinical-biological markers[J].BMC Med Imaging,2016,16(1):37.DOI:10.1186/s12880-016-0139-7. [23]KANG B,CHOI S Y,CHI S,et al.Baseline wall thickness is lower in mucosa-healed segments 1 year after infliximab in pediatric crohn disease patients[J].J Pediatr Gastroenterol Nutr,2017,64(2):279-285.DOI:10.1097/MPG.0000000000001222. [24]HUH J,KIM K J,PARK S H,et al.Diffusion-weighted MR enterography to monitor bowel inflammation after medical therapy in Crohn's disease:a prospective longitudinal study[J].Korean J Radiol,2017,18(1):162-172.DOI:10.3348/kjr.2017.18.1.162. [25]CASTIGLIONE F,MAINENTI P,TESTA A,et al.Cross-sectional evaluation of transmural healing in patients with Crohn's disease on maintenance treatment with anti-TNF alpha agents[J].Dig Liver Dis,2017,49(5):484-489.DOI:10.1016/j.dld.2017.02.014. [26]KUCHARZIK T,WITTIG B M,HELWIG U,et al.Use of intestinal ultrasound to monitor Crohn's disease activity[J].Clin Gastroenterol Hepatol,2017,15(4):535-542.e2.DOI:10.1016/j.cgh.2016.10.040. [27]DILLMAN J R,DEHKORDY S F,SMITH E A,et al.Defining the ultrasound longitudinal natural history of newly diagnosed pediatric small bowel Crohn disease treated with infliximab and infliximab-azathioprine combination therapy[J].Pediatr Radiol,2017,47(8):924-934.DOI:10.1007/s00247-017-3848-3. [28]LOPES S,ANDRADE P,CUNHA R,et al.Transmural healing in Crohn's disease:beyond mural findings[J].Dig Liver Dis,2018,50(1):103-104.DOI:10.1016/j.dld.2017.09.134. [29]STURM A,MAASER C,CALABRESE E,et al.ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 2:IBD scores and general principles and technical aspects[J].J Crohns Colitis,2019,13(3):273-284.DOI:10.1093/ecco-jcc/jjy114. [30]TAKENAKA K,OHTSUKA K,KITAZUME Y,et al.Correlation of the endoscopic and magnetic resonance scoring systems in the deep small intestine in Crohn's disease[J].Inflamm Bowel Dis,2015,21(8):1832-1838.DOI:10.1097/MIB.0000000000000449. [31]RIMOLA J,ORDáS I,RODRIGUEZ S,et al.Magnetic resonance imaging for evaluation of Crohn's disease:validation of parameters of severity and quantitative index of activity[J].Inflamm Bowel Dis,2011,17(8):1759-1768.DOI:10.1002/ibd.21551. [32]RIPOLLéS T,PAREDES J M,MARTíNEZ-PéREZ M J,et al.Ultrasonographic changes at 12 weeks of anti-TNF drugs predict 1-year sonographic response and clinical outcome in Crohn's disease:A multicenter study[J].Inflamm Bowel Dis,2016,22(10):2465-2473.DOI:10.1097/MIB.0000000000000882. [33]SAUER C G,KUGATHASAN S,MARTIN D R,et al.Medical radiation exposure in children with inflammatory bowel disease estimates high cumulative doses[J].Inflamm Bowel Dis,2011,17(11):2326-2332.DOI:10.1002/ibd.21626. |
[1] | YAO Yuzhong, MA Xiaojun, SONG Huan, ZHONG Yu. The Management Effect of Diabetes "1358 model" on Community Diabetes Patients Based on "Precision Management Combining General Care and Specialty Care" [J]. Chinese General Practice, 2023, 26(34): 4308-4314. |
[2] | LI Qian, ZHANG Yunshu, YAN Baoping, WANG Jian, MA Yanjuan, WANG Yuan, QIN Yingjie, NA Long, REN Zhiyong, SUN Junwei, DENG Huaili, MA Hongjun, QU Xuehui, ZHOU Nan, SI Tianmei. Efficacy and Safety of Risperidone Microspheres for Injection (Ⅱ) in the Treatment of Patients with Acute Schizophrenia [J]. Chinese General Practice, 2023, 26(32): 4007-4012. |
[3] | SUN Xiaolei, LEI Xiaolong, LIN Jiasheng, LI Keliang, GUO Ao, ZHANG Xiaohui. Effect of High Intensity Laser Combined with Physiotherapy Scoliosis Specific Exercise Therapy on Ultrasound Morphology of Multifidus Muscles in Idiopathic Scoliosis Patients with Low Back Pain [J]. Chinese General Practice, 2023, 26(27): 3456-3462. |
[4] | YAO Junjie, SHANG Qiangqiang, WANG Yufeng, LI Jiahui, LIU Chang, PANG Tingting. Wearable Inertial Sensors-based Efficacy Evaluation of Comprehensive Traditional Chinese Medicine Therapy for Lumbar Disc Herniation Due to Qi-stagnation and Blood-stasis [J]. Chinese General Practice, 2023, 26(27): 3450-3455. |
[5] | LIU Minghao, WANG Pan, GAO Lijian, XU Shuqing, WANG Huanhuan, ZHAO Guangxian, CHEN Jue, QIAO Shubin, XU Bo, YUAN Jinqing. Feasibility, Safety and Timing of Secondary Percutaneous Coronary Intervention via Distal Transradial Artery Approach [J]. Chinese General Practice, 2023, 26(27): 3366-3372. |
[6] | LU Bin, XIANG Chong, YUAN Xuesong, CAI Gaojun, WEI Wenfeng, YAN Yongmin. Effectiveness, Safety and Satisfaction of Distal Transradial Artery Approach in Cerebral Angiography [J]. Chinese General Practice, 2023, 26(27): 3378-3382. |
[7] | BAI Yitong, LIN Lianjie, PEI Dongmei. Correlation between the Severity of Metabolic-associated Fatty Liver Disease and Thyroid Nodules [J]. Chinese General Practice, 2023, 26(27): 3392-3396. |
[8] | JI Mengying, LI Yujing, CHEN Xing, DAI Huihua, SUN Ying. Prediction Value of B-ultrasound with Tumor Markers for Malignant Transformation of Mucinous Ovarian Tumors [J]. Chinese General Practice, 2023, 26(24): 3022-3027. |
[9] | REN Yuanyuan, CHENG Gong, JIANG Hongying, WANG Yiyang, CHEN Liang, ZHAO Hui, LIANG Chenyuan. Analysis of Influencing Factors of Coronary Artery Calcification and Its Severity in Patients with Coronary Heart Disease [J]. Chinese General Practice, 2023, 26(24): 2980-2985. |
[10] | GAO Yang, WANG Yunxia, GAO Chuanyu. Familial Hypercholesterolemia in 45-year-old and Younger Patients with Acute Coronary Syndrome: Clinical Characteristics and Influencing Factors of Blood Lipid Control Effect [J]. Chinese General Practice, 2023, 26(18): 2232-2237. |
[11] | YANG Bei, HAN Lin, WANG Yin, CHENG Kangyao. Effectiveness of Continuous Subcutaneous Insulin Injection in Type 2 Diabetes in Older Adults: a Meta-analysis and Trial Sequential Analysis [J]. Chinese General Practice, 2023, 26(15): 1892-1901. |
[12] | LIU Chuanfen, LI Zheng, WU Manyan, CUI Yuxia, SONG Jing, ZHANG Chunying, CHEN Hong. Analysis of Serum Lipid Level and Drug Use in Patients with Acute Myocardial Infarction [J]. Chinese General Practice, 2023, 26(11): 1325-1329. |
[13] | FEI Jingwen, LIN Huize, ZHANG Pingping, LIU Lanping, WANG Xiang, SHEN Jianghong, ZHU Kexin, YANG Tao, YU Jinna. Motion Style Acupuncture Can Effectively Improve the Effectiveness of Acute Nonspecific Low Back Pain: a Meta-analysis [J]. Chinese General Practice, 2023, 26(09): 1044-1052. |
[14] | GUAN Ningxiao, YAO Zhuoya, LI Ye, LIU Ziwei, LIU Fangli. Non-invasive Brain Stimulation Techniques Can Effectively Relieve Post-stroke Fatigue: a Meta-analysis [J]. Chinese General Practice, 2023, 26(08): 1008-1014. |
[15] | HUANG Tao, LUO Na, LUO Song, XU Qin. Clinical Application of a Novel Noninvasive Positive Pressure Ventilation Face Mask with Two Channels and Constant Leakage for Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease and Carbon Dioxide Retention [J]. Chinese General Practice, 2023, 26(03): 343-347. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||